Did You Know? The most common lung cancer gene mutation is the EGFR gene.
Last updated: 20 Mar 2026
626 Views
Lung cancer is a leading cause of death among Thais, particularly in the non-smoking group. One of the factors that causes the disease to develop unknowingly is "gene mutation," specifically a key gene called EGFR (Epidermal Growth Factor Receptor).
According to data from the Thai Lung Cancer Group, it was found that:
"More than 50% of lung cancer patients in Thailand have the EGFR gene mutation."【1】
What is the EGFR gene?
EGFR is a gene involved in the growth of cells in the body. If a mutation occurs, this gene causes cells to grow abnormally fast, eventually turning into cancer cells—especially in Non-Small Cell Lung Cancer (NSCLC).
EGFR mutations are most commonly found in women, non-smokers, and individuals of Southeast Asian descent.
Why is EGFR testing important?
✅ To assess "lung cancer risk" in asymptomatic individuals. ✅ To aid in diagnosis and select precise treatment pathways (specifically Targeted Therapy). ✅ To plan long-term health management for those with a family history of cancer. ✅ To be used alongside other gene tests for an in-depth cancer risk analysis.
Where can you get an EGFR gene test?
You can now get tested for the EGFR gene at all 7 branches of PathLab Health Screening Centers.
The sample collection process is simple, convenient, and safe.
With the SUPERGENIX Program: Supreme DNA Test (1,700+ items), covering essential reports:
Lung Cancer Gene (EGFR)
Other Cancer Genes such as BRCA1, BRCA2
Risk of other chronic diseases like Heart Disease, Diabetes, and Dyslipidemia
Health behaviors related to an individual's unique genetic makeup
Get tested today for informed prevention
Knowing whether your body carries the EGFR mutation is the true starting point for in-depth health care, especially for diseases that do not show symptoms in the early stages, like lung cancer.
The sooner you know, the better you can prepare. "Prevention is better than cure."
PathLab: We care about your health.
References
Thai Lung Cancer Group. EGFR mutations in Thai lung cancer patients: epidemiology and clinical relevance.
American Cancer Society. Targeted Therapy for Non–Small Cell Lung Cancer.
National Cancer Institute (NCI). EGFR Gene and Cancer.
According to data from the Thai Lung Cancer Group, it was found that:
"More than 50% of lung cancer patients in Thailand have the EGFR gene mutation."【1】
What is the EGFR gene?
EGFR is a gene involved in the growth of cells in the body. If a mutation occurs, this gene causes cells to grow abnormally fast, eventually turning into cancer cells—especially in Non-Small Cell Lung Cancer (NSCLC).
EGFR mutations are most commonly found in women, non-smokers, and individuals of Southeast Asian descent.
Why is EGFR testing important?
✅ To assess "lung cancer risk" in asymptomatic individuals. ✅ To aid in diagnosis and select precise treatment pathways (specifically Targeted Therapy). ✅ To plan long-term health management for those with a family history of cancer. ✅ To be used alongside other gene tests for an in-depth cancer risk analysis.
Where can you get an EGFR gene test?
You can now get tested for the EGFR gene at all 7 branches of PathLab Health Screening Centers.
The sample collection process is simple, convenient, and safe.
With the SUPERGENIX Program: Supreme DNA Test (1,700+ items), covering essential reports:
Lung Cancer Gene (EGFR)
Other Cancer Genes such as BRCA1, BRCA2
Risk of other chronic diseases like Heart Disease, Diabetes, and Dyslipidemia
Health behaviors related to an individual's unique genetic makeup
Get tested today for informed prevention
Knowing whether your body carries the EGFR mutation is the true starting point for in-depth health care, especially for diseases that do not show symptoms in the early stages, like lung cancer.
The sooner you know, the better you can prepare. "Prevention is better than cure."
PathLab: We care about your health.
References
Thai Lung Cancer Group. EGFR mutations in Thai lung cancer patients: epidemiology and clinical relevance.
American Cancer Society. Targeted Therapy for Non–Small Cell Lung Cancer.
National Cancer Institute (NCI). EGFR Gene and Cancer.
Related Content
